BNP Paribas Financial Markets’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
BNP Paribas Financial Markets's CLBT Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Cellebrite (CLBT) stake by 94% in Q2 2026, selling an estimated $1.41M and leaving 7,142 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #4521.
BNP Paribas Financial Markets first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.85M in Q1 2025. 186 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- BNP Paribas Financial Markets held 7,142 shares of Cellebrite worth $104K as of Q2 2026.
- BNP Paribas Financial Markets sold 106,977 Cellebrite shares in Q2 2026, an estimated $1.41M.
- Cellebrite made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4521 holding.
- BNP Paribas Financial Markets first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
- BNP Paribas Financial Markets's Cellebrite position peaked at $7.85M in Q1 2025.
- 186 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.